RxDoctor Payments Data

Eric Petersen, DO

Family Medicine · Maquoketa, IANPI 1538149042

Payments from drug & device makers

$1,569in general payments, 2019–2025

Across 76 payments — averaging $20.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$429
  • Teva Pharmaceuticals USA, Inc.$250
  • AbbVie$189
  • AstraZeneca$153
  • Novo Nordisk$150
  • Astellas Pharma US Inc$128
  • plus $271 from 8 others

What the payments were for

  • Food & beverage$1,28382%
  • Education$28618%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,569 in reported general payments places this provider in the 85th percentile of 1,357 family medicine providers in Iowa.

See all family medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$154,994
Medicare patients
468
Services billed
15,040

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban205$102,472
JardianceEmpagliflozin128$84,321
MounjaroTirzepatide70$75,955
FarxigaDapagliflozin Propanediol114$75,815
Trelegy ElliptaFluticasone/Umeclidin/Vilanter74$53,581
OzempicSemaglutide46$52,366
Invega SustennaPaliperidone Palmitate13$47,916
JanuviaSitagliptin Phosphate24$33,938
MyrbetriqMirabegron70$16,783
Janumet XrSitagliptin Phos/Metformin Hcl25$14,026
XareltoRivaroxaban14$13,613
RybelsusSemaglutide11$12,797
RexultiBrexpiprazole30$11,427
RytaryCarbidopa/Levodopa48$9,787
Potassium Chloride502$8,454

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$429$102,472205 claims
Boehringer IngelheimJardiance$27$84,321128 claims
AstraZenecaFarxiga, Breztri Aerosphere$153$82,648125 claims
Lilly USA, LLCMounjaro, Olanzapine$87$79,054291 claims
Novo NordiskOzempic, Rybelsus$150$65,16257 claims
Astellas Pharma US IncMyrbetriq$128$16,78370 claims
Otsuka America Pharmaceutical, Inc.Rexulti$14$11,42730 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,357 family medicine providers in Iowa.

Other family medicine in Maquoketa

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →